AI-generated summary
The authors retrospectively reviewed 230 patients with severe meibomian gland dysfunction who had failed prior medical treatment and received combined intense pulsed light and low-level light therapy. They report lower symptom scores, improved gland grading and longer tear breakup times after treatment, with no adverse events. Limitations include the retrospective design and the absence of a control group.
- Participants
- 230
- Who or what was studied
- Patients with severe meibomian gland dysfunction who had failed prior topical and/or systemic therapy, treated at 3 centers by 4 physicians
- Limits stated in the abstract
- The study was a retrospective chart review without a control group.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on dovepress.com.
Record from PubMed, a service of the National Library of Medicine.
How to read a single study: what to check before relying on this kind of research.
Terms in this paper: Low-level laser therapy, Dry eye. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.